Literature DB >> 24002516

How to incorporate new tyrosine kinase inhibitors in the treatment of patients with medullary thyroid cancer.

Robert I Haddad1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24002516     DOI： 10.1200/JCO.2013.51.5098

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm.

Authors:  Barbara Jarzab; Jolanta Krajewska
Journal:  Eur Endocrinol       Date:  2014-08-28

Review 2.  Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.

Authors:  Na Qu; Zongguang Hui; Zhixin Shen; Chengxia Kan; Ningning Hou; Xiaodong Sun; Fang Han
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

3.  High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.

Authors:  Michele Simbolo; Caterina Mian; Susi Barollo; Matteo Fassan; Andrea Mafficini; Diogo Neves; Maria Scardoni; Gianmaria Pennelli; Massimo Rugge; Maria Rosa Pelizzo; Elisabetta Cavedon; Laura Fugazzola; Aldo Scarpa
Journal:  Virchows Arch       Date:  2014-05-15       Impact factor: 4.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.